Venrock Healthcare Capital Partners III L.P. 13D and 13G filings for CASI Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 6:04 pm Purchase | 2025-12-31 | 13G | CASI PHARMACEUTICALS HLDGS INC CASIF | Venrock Healthcare Capital Partners III L.P. | 1,987,259 9.200% | 480,219 (+31.87%) | Filing |
| 2024-07-25 8:48 pm Purchase | 2024-07-15 | 13G | CASI PHARMACEUTICALS HLDGS INC CASIF | Venrock Healthcare Capital Partners III L.P. | 1,507,040 9.990% | 1,507,040 (New Position) | Filing |